Scaling Up Covid-19 Vaccination in Africa - Lessons from the HIV Pandemic

Affiliation

• ¹ From the Departments of Epidemiology and of Infectious Diseases and Microbiology and the Center for Global Health, University of Pittsburgh Graduate School of Public Health (J.B.N.); and the Division of Infectious Diseases, Department of Medicine, University of Pittsburgh School of Medicine (J.W.M.) - both in Pittsburgh; the Department of Medicine and the Center for Infectious Diseases, Stellenbosch University, Faculty of Medicine and Health Sciences, Cape Town, South Africa (J.B.N.); the Departments of Epidemiology and International Health, Johns Hopkins Bloomberg School of Public Health (J.B.N.), and the Department of Pediatrics and the Institute of Human Virology, University of Maryland School of Medicine (N.A.S.-A.) - both in Baltimore; the Pediatric/Adolescent HIV Unit and International Research Center of Excellence, Institute of Human Virology Nigeria, Abuja, Nigeria (N.A.S.-A.); the Department of Pediatrics and Child Health, School of Medical Sciences, University of Cape Coast, Cape Coast, Ghana (N.A.S.-A.); the Division of Infection and Immunity, University College London, and the NIHR Biomedical Research Centre, University College London Hospitals - both in London (A.Z.); the African Forum for Research and Education in Health, Kumasi, Ghana (J.B.N., N.A.S.-A., A.Z.); and the Elizabeth Glaser Pediatric AIDS Foundation, Washington, DC (L.M.M.).